Good day, 360 –

Here are our top investing ideas today – these setups look primed! Be the best prepared trader on the Street! And if you missed Jeff Bishop’s State of the Union yesterday, watch it here on-demand and get a taste of what this seasoned educator and trader as to offer.

NEPT – Up over 70% in pre-market after debt for equity term sheet with Morgan Stanley for Sprout Organics

DRTS – Up over 19% after releasing robust long-term safety and efficacy data from multiple clinical trials of alpha dart cancer treatment

HE – Up over 20% after a filling this morning stating the goal is not to restructure the company.

NEPT – Up over 70% in pre-market after debt for equity term sheet with Morgan Stanley for Sprout Organics

Neptune Wellness Solutions Inc (NEPT) operates as a consumer packaged goods company in Canada, the United States and internationally. Its product portfolio includes Omega-3 fish oils and other nutritional products.

In the after-hours the company announced it had entered into a binding term sheet with NH Expansion Credit Fund Holdings L.P. (“Morgan Stanley” or “MSEC”) for the company’s organic baby and toddler food brand, Sprout Organics. This gives Neptune an option to exchange its existing Sprout debt for Sprout equity, on or prior to November 13, 2023 (the “Exchange”). The Exchange would substantially reduce Sprout’s debt.

The company also reported mixed earnings.

The stock is up over 70% on the news.

The $0.25 area has been resistance in the after-hours and pre-market and will be an important level to watch.

The first major target for bulls is the after-hours high at $0.26. Beyond that, $0.30, $0.35 come into play with a gap fill at $0.4050.

DRTS – Up over 19% after releasing robust long-term safety and efficacy data from multiple clinical trials of alpha dart cancer treatment

Alpha Tau Medical Ltd. (DRTS) a clinical-stage oncology therapeutics company, engages in research, development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States.

• 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.

• Two-year local recurrence-free survival rate of 77%.

• The analysis also showed no grade 3 or higher acute treatment-related toxicities, with approx. 20% of patients experiencing acute grade 2 toxicities.

• No grade 2 or higher late toxicities were observed 6 months after treatment.

The stock is up 19% in pre-market on the news.

$4.40 has been a resistance level in the pre-market and will be an important area to watch.

Above it, targets to the upside are $4.50, $4.60 and then the after-hours high of $5. Beyond that, $5.20, $5.80 and $6 come into play.

Below $4.40 there is potential support at $4.15, $4, $3.80 and a gap to fill at $3.60.

HE – Up over 20% after a filing this morning stating the goal is not to restructure the company.

Hawaiian Electric Industries (HE) together with its subsidiaries, engages in the electric utility, banking, and non-regulated renewable/sustainable infrastructure investment businesses in the state of Hawaii.

The stock is down over 50% post the wildfires in Hawaii. Yesterday the stock was up post the open on record volume. This morning the company stated in a filing that its goal is not to restructure the company.

The stock is up over 20% this morning in the pre-market.

The $14.70 area was support turned resistance and will be an important level to watch.

Above it, targets to the upside are $16.50, $18.70, $20 and then $22.

Below $14.70, there is potential support at $12 and $10.05.

Please see disclosures below.

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull